- ►diabetesjournals.org SM Strowig, ML Avilés-Santa, P Raskin - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—HbA 1c levels decreased in both groups during dual therapy and
improved further during triple therapy (INS + MET 7.0 ± 0.8, INS + TGZ 6.2 ±
0.8, P < 0.0001; INS + MET, add TGZ 6.1 ± 0.4%, P < 0.001; INS + TGZ, add ... Cited by 49 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org SM Strowig, ML Avilés-Santa, P Raskin - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—HbA lc levels decreased in all groups, the lowest level occurring in
the insulin plus troglitazone group (insulin alone to 7.0%, insulin plus
metformin to 7.1%, and insulin plus troglitazone to 6.4%, P < 0.0001). The ... Cited by 61 - Related articles - BL Direct - All 6 versions
- Free from Publisher MK Poulsen, JE Henriksen, O Hother-Nielsen, … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Sixteen obese type 2 diabetic outpatients on human
NPH or MIX (regular + NPH insulin) insulin twice daily were randomized to either
triple therapy, ie, insulin aspart (a rapid-acting insulin analog) at ... Cited by 56 - Related articles - BL Direct - All 6 versions
SM Strowig, P Raskin - Diabetes Obesity and Metabolism, 2005 - interscience.wiley.com The biguanide, metformin, sensitizes the liver to the effect of insulin,
suppressing hepatic glucose output. Thiazolidinediones such as rosiglitazone and
pioglitazone enhance insulin-mediated glucose disposal, leading to reduced ... Cited by 20 - Related articles - BL Direct - All 5 versions
- Free from Publisher MG Wulffelé, A Kooy, P Lehert, D Bets, JC … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Metformin improves glycemic control in poorly
controlled type 2 diabetic patients. Its effect in type 2 diabetic patients who
are intensively treated with insulin has not been studied. A total of 390 ... Cited by 68 - Related articles - BL Direct - All 5 versions
GE Dailey, MA Noor, JS Park, S Bruce, FT … - The American journal of medicine, 2004 - Elsevier Following an open-label, lead-in phase to optimize the dosing of
glyburide/metformin tablets, 365 patients randomly received additive therapy
comprising rosiglitazone (4 mg once daily) or placebo for 24 weeks. Based ... Cited by 64 - Related articles - All 9 versions
- ►diabetesjournals.org S Colagiuri, CA Cull, RR Holman - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—Fewer people with FPG in the lowest category had retinopathy, abnormal
biothesiometer measurements, or reported erectile dysfunction. The rate of
increase in FPG and HbA 1c during the study was identical in all three ... Cited by 14 - Related articles - All 2 versions
[CITATION] VA CSDM Group: VA Cooperative study on glycemic control and complications in type II …
